"Tech Prophet" Who Predicted the iPhone Now Predicts...
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit the most.
Shutdown stalemate set to drag into sixth week as Trump pushes Republicans to change Senate rules
WASHINGTON (AP) — Republicans and Democrats remained at a stalemate on the over the weekend as it headed into its sixth week, with for millions of Americans and President Donald Trump pushing GOP leaders to change Senate rules to end it.
Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.
Trump's Hidden Fed Agenda - Ad
Trump's latest moves show he's preparing to reshape the Federal Reserve - and the value of the U.S. dollar. With key appointees already in place, the coming monetary reset could send gold soaring like it did in the 1970s, when it climbed 24X in under a decade.
Trump may become the face of economic discontent, a year after such worries helped him win big
WASHINGTON (AP) — President got a serious that he’s out of touch with their fears about a deteriorating U.S. economy.
Deep in Trump country, coal miners with black lung say government is suffocating the 'working man'
OAK HILL, W.Va. (AP) — Lisa Emery loves to talk about her “boys.” With each word, the respiratory therapist’s face softens and shines with pride. But keep her talking, and it doesn’t take long for that passion to switch to hurt. She knows the names, ages, families and the intimate stories of each one’s scarred lungs. She worries about a whole community of West Virginia coal miners — including a growing number in their 30s and 40s — who come to her for help while getting sicker and sicker from what used to be considered an old-timer’s disease: black lung.
America's Defense Future Starts Underground - Ad
A N. American metals project just caught the attention of Rio Tinto - a mining giant. With four projects in key regions, this firm is aligned with Washington's push to rebuild the defense-metal supply chain.
Be Well: Breaking down fiber, the next food fad
U.S. consumers who have had their fill of finding to everything from cereal to ice cream are about to meet the next big food fad: fiber.
FDA Clears Arrowhead Pharma's First-Ever Home Injection For Rare Fat Disorder
Arrowhead Pharmaceuticals won FDA approval for Redemplo (plozasiran), an siRNA drug reducing high triglycerides in adults with rare FCS.
Congress to Feature Trump on $100 Bill? - Ad
A shocking new plan was just introduced in Washington; to celebrate Trump's new "golden age" by placing him on the $100 bill. In the months ahead, this former Presidential Advisor predicts the government will release a massive multi-trillion-dollar asset which it has held back for more than a century.
Annovis Bio Stock Jumps As New Data Shows Buntanetap Halts Cognitive Decline In Parkinson's Patients
Annovis Bio rises after Phase 3 data show buntanetap halted decline in Parkinson's patients, with results in those with amyloid co-pathology.
Novo Nordisk Leans Into Affordability Amid Rising Competition
Novo Nordisk offers limited-time $199 pricing on Wegovy and Ozempic, lowers self-pay costs, and prepares for a stronger Wegovy pill rollout.
Gold Near $4,073. Copper Tight. This Drill Hit Came Just in Time. - Ad
Dual exposure to two surging metals, plus 17.91% CuEq over mineable width, and infrastructure on site - this is what juniors dream of. And the market is just starting to notice.
Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know
A judge said Friday that he planned to approve a deal and members of the Sackler family who own the company to settle thousands of lawsuits over the toll of opioids, allowing money to start flowing to victims as soon as next spring.
Hims & Hers Introduces Labs With Annual Plans For Comprehensive Testing
Hims & Hers launches Labs, offering annual biomarker testing plans with doctor-developed guidance and expanded diagnostics planned across key health categories.
Crypto Set to Skyrocket? (Do This Now!) - Ad
Biden-era crackdowns failed. Under Trump, crypto is entrenched with a Strategic Bitcoin Reserve, a pro-crypto SEC chair, and lawsuits dropped. Bitcoin, Ethereum, Ripple, and Solana have surged. A new law could open a $19T crypto boom, with ways to benefit without buying coins.
Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial
Gilead's Phase 3 ARTISTRY-1 trial shows its single-tablet HIV regimen of bictegravir and lenacapavir matches the efficacy and safety of current therapy.
Applied Therapeutics Tanks As FDA Path For Lead Rare-Disease Drug Turns Uncertain
Applied Therapeutics stock falls after FDA feedback prompts another Type C meeting to discuss the Phase 3 plan for its CMT-SORD drug govorestat.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit the most.
Federal workers question whether the longest government shutdown was worth their sacrifice
WASHINGTON (AP) — Jessica Sweet spent cutting back. To make ends meet, the Social Security claims specialist drank only one coffee a day, skipped meals, cut down on groceries and deferred paying some household bills. She racked up spending on her credit card buying gas to get to work.
2 new malaria treatments announced as drug resistance grows
NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
More than 80 nonprofits receive $250M for global women's health from Melinda French Gates
More than 80 organizations that provide health care for women all over the world received grants Wednesday totaling after a year-long application process.
House returns for vote to end the government shutdown after nearly 2 months away
WASHINGTON (AP) — House lawmakers will make a long-awaited return to the nation's capital on Wednesday after nearly eight weeks away to potentially put an end to the longest in U.S. history.
Trump Orders New Wealth Fund for America - Ad
"We're going to monetize the most valuable asset of the United States." What did Trump's Treasury Secretary mean when he said this? As you'll see, Trump could soon unleash a massive new boom in America. One that could dwarf the rise of crypto and NVIDIA, combined.
Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact
BofA expects Medtronic to post over 5% second-quarter revenue growth and maintain strong momentum through 2026, driven by robust procedure trends.
AstraZeneca's Investigational Hypertension Drug Shows Significant Blood Pressure Control In Pivotal Trial
AstraZeneca's Baxdrostat cut blood pressure by 14 mmHg in the Phase 3 Bax24 trial, showing strong efficacy and safety in resistant hypertension patients.
Metals... Not Missles... Is the New Arms Race - Ad
China and Russia control 70% of the world's critical minerals, giving them leverage over the West. One N. American discovery could help shift that balance by developing the metals essential for defense systems.
A deal to end the government shutdown is on track but faces hurdles
WASHINGTON (AP) — A legislative package to end appears on track Monday after a handful of Senate Democrats joined with Republicans to break the impasse in what has become of federal , the longest in history.
What to know about COP30, this year's UN climate talks
People from around the world are beginning to gather at the gateway of the Amazon in Belem, Brazil, for the 30th annual United Nations climate summit, the Conference of the Parties, known less formally as COP30.
From Strong to Stunning: New Drill Hole Sets a New Bar - Ad
Earlier holes showed 2.4% and 2.7% CuEq. This new hit just delivered 6.93% over nearly 20 metres. That's a game-changer - and it comes with deep insider alignment and an active program.
Last monkey on the loose after Mississippi highway crash is captured after being spotted by resident
HEIDELBERG, Miss. (AP) — The last monkey on the loose among several that escaped after a Mississippi highway crash has been found and captured, authorities said Thursday.
Becton Dickinson Sees High Single-Digit Profit Growth Ahead, Plans Share Buybacks From Waters Deal
Becton Dickinson posts Q4 earnings beat, raises FY26 EPS outlook, with strong growth in Medical and Interventional segments despite China headwinds.
Trump's Hidden Fed Agenda - Ad
Trump's latest moves show he's preparing to reshape the Federal Reserve - and the value of the U.S. dollar. With key appointees already in place, the coming monetary reset could send gold soaring like it did in the 1970s, when it climbed 24X in under a decade.
Ozempic Maker Novo Nordisk Trims Growth Outlook For Obesity Drugs
Novo Nordisk Q3 profit drops on restructuring costs as GLP-1 and obesity drug sales rise; company narrows 2025 growth outlook.
Zoetis Stock Outlook Clouded By Rising Competitive Pressures
Zoetis tops Q3 earnings estimates but trims 2025 sales forecast as companion animal growth slows and competition weighs on its outlook.
America's Defense Future Starts Underground - Ad
A N. American metals project just caught the attention of Rio Tinto - a mining giant. With four projects in key regions, this firm is aligned with Washington's push to rebuild the defense-metal supply chain.
Why Is Rein Therapeutics Stock Trading Higher On Monday?
Rein Therapeutics shares rise after the FDA lifts clinical hold on its Phase 2 RENEW trial for idiopathic pulmonary fibrosis treatment LTI-03.
UniQure Shares Drop After FDA Shifts Stance On Huntington's Gene Therapy Data
UniQure shares fell after the FDA questioned the adequacy of data supporting its AMT-130 gene therapy for Huntington's disease, delaying BLA plans.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.